Physician profile
Richard A Hopkins
NPI 1801871413
$40,589.51
in general payments reported to CMS, 2019-2025
13 companies · $181 in 2025
The $181 reported for 2025 was more than what a typical Undersea and Hyperbaric Medicine (Emergency Medicine) provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $6,492 · 2020: $4,675 · 2021: $5,198 · 2022: $14K · 2023: $10K · 2024: $125 · 2025: $181.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $10K · Food and Beverage: $306.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $10,037.50 |
| Food and Beverage | $306.34 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Csl Behring | $7,150.00 | 2022 | |
| Endologix LLC | $6,600.00 | 2022 | |
| Medtronic Vascular, INC. | $6,275.09 | 2019 | |
| Edwards Lifesciences Corporation | $5,225.00 | 2023 | |
| Neovasc Medical INC | $5,197.50 | 2021 | |
| Sarepta Therapeutics, INC. | $4,812.50 | 2023 | |
| Bard Peripheral Vascular, INC. | $4,675.00 | 2020 | |
| Smith+Nephew, INC. | $242.21 | 2019-2025 | Collagenase Santyl |
| Integra Lifesciences Corporation | $203.75 | 2019-2025 | Tcc-Ez |
| Organogenesis INC. | $108.38 | 2024 | |
| Bsn Medical INC | $62.03 | 2025 | |
| Pfizer INC. | $21.21 | 2025 | |
| Mimedx Group, INC. | $16.84 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Richard Hopkins listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.